Skip to content

About Ecohydra

EcoHydra Technologies Ltd (EcoHydra) is dedicated to delivering superior hand hygiene formulations which are both effective, yet kind to the skin, unlike harsh alcohol-based products.

The EcoHydra range includes hand sanitisers, hand wash, hand lotion and a barrier cream, which are all alcohol and Triclosan free and have been thoroughly tested and certified by independent laboratories to effectively kill up to 99.9999% of bacteria within 30 seconds of application.

Each product in the EcoHydra range is extremely safe and gentle containing the natural moisturiser, Aloe Vera, to nourish and care for the skin, and encourage regular use as often as needed.

Our EcoHydra hand hygiene products are so effective they are also used in a variety of demanding environments where protection against infection is paramount; including NHS hospitals where the EcoHydra Hand Sanitiser is used as an alternative to harsh alcohol-based gels. It also has the added advantage of being effective against Norovirus.

The EcoHydra product range is available to buy from selected pharmacies and online stockists. The alcohol free Antibacterial Hand Sanitiser is technically approved for free sale throughout the UK NHS and is listed on the NHS Supply Chain Framework.

Directors of EcoHydra Technologies Limited

Clifton Melvin

Chairman
Expertise: Strategic Leadership

Clifton Melvin joined EcoHydra as Chairman in 2004 after a long and successful career in the financial services.  British born, Clifton has a degree from Oxford University and is a Fellow of the Institute of Actuaries.  A fluent Spanish speaker, he has held senior management positions with Axa, KPMG, GE Capital and Credit Suisse, where he was the Chief Executive of Winterthur Life UK from 2001 to 2003.  Clifton was the Senior Independent Director of life insurance company 'Just Retirement' from 2004 to 2013 where he also chaired the Risk and Compliance Committee. He is a member of the Standard Life with Profits Committee and a non-executive director of Saga Services Limited where he chairs the audit Committee.

John Appleby

Managing Director

Expertise: Strategic Brand Management and Business Management

John joined EcoHydra in April 2014 and is a seasoned business professional with 30 years of experience in Country and Category Marketing, Sales and General Management in the Consumer and Prescription healthcare industry both in the UK and Internationally

The majority of his career has been spent with Crookes Healthcare and Boots Healthcare International (BHI) during which time he successfully managed and grew the Global Analgesic, Throat Care and Dermatological categories. He also led and developed the BHI business in the Far East establishing the BHI presence in Japan. His last role prior to the acquisition of BHI by Reckitt Benckiser was managing the Middle East, Mediterranean and African Region for which he had developed and was implementing an aggressive growth strategy

Following the sale of BHI John established his own consultancy in 2006 specialising in consumer healthcare called ahca Specialist Healthcare Consultants.   

Charles Whait

Sales Director
Expertise: UK & International Business Development

Charles joined EcoHydra in 2007 as Sales Director and has an extensive sales and marketing background in the healthcare sector. His expertise includes product and sales development within the UK NHS and identifying and establishing international sales opportunities.

Brian Warneford

Financial Controller and Company Secretary
Expertise: Financial Management

Brian joined EcoHydra in 2004 and is a Chartered Accountant with his own accountancy practice. He has extensive experience advising both large and small companies, including international pharmaceutical distributors. He advises the Company on accounting requirements, financial reporting and statutory reporting obligations.

Nick May

Director
Expertise: IT

Nick is one of the founders of EcoHydra and provides management and IT services to the company. He has a career background in IT consultancy working for blue chip clients, is the architect of the website EvolveMyRetirement.com and speaks several languages fluently.

Non-Executive Directors of EcoHydra Technologies Limited

Leslie Barber

Leslie is a portfolio NED with board level retail experience. He has had a highly successful executive career with international marketing and brand-building experience in organisations such as Unilever and Lornamead. He has led our successful negotiations with both Boots and Amazon.

Charles Goodson-Wickes

Charles is a Physician, Barrister and former MP with outstanding career achievements at Executive and Board level and with a wide range of commercial contacts. He is the Chairman of Thomas Greg and Sons Ltd., international Security Printers. He has previously served on the boards of 2 FTSE 250 Health sector companies – Nestor Healthcare Group plc, and medical devices company Gyrus Group plc.

Advisors to the Board

Martin Robinson

Martin has a wealth of experience in running and growing a diverse range of businesses, he is currently Chairman of Casual Dining Group and also the Chairman of Inspiring Learning.

He is also an operating Partner of Duke Street Capital and a non-Executive Director of Euro Disney and Masif Al Futaim and his expertise and advice will be invaluable as we grow the EcoHydra business and ultimately consider exit strategies

Professor Duncan Eaton

Professor Duncan Eaton is a past Chief Executive of the NHS Purchasing and Supply Agency and was previously Chief Executive of Bedfordshire Health Authority.  He is currently Chairman of Kimal Holdings Ltd, a company supplying medical devices and services to the NHS as well as to UK and International private healthcare markets.  He is also an Executive Adviser with the All Party Parliamentary Health Group and a member of the Advisory Panel of Doctors.net.

Dr Carl Edwards

Microbiologist
Expertise: Technical expert in microbiology and commercial application of product development

Carl is an eminent microbiologist with extensive experience including drug development, clinical trials, due diligence, technology transfer, market research and negotiation of commercial licensing. He is well published in technical journals and has been a lead figure in the development of business strategies, including therapeutics, diagnostics and biotechnology. Carl guides the Executive Team in commercial application and further technical development of products.


Back to Top